HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Auditory and visual event-related potentials in patients suffering from Alzheimer's dementia and multiinfarct dementia, before and after treatment with piracetam.

Abstract
We have done a study on 7 subjects suffering from Alzheimer's dementia (AD) and 15 subjects suffering from multiinfarct dementia (MID) to see whether they manifest any changes of amplitudes or latencies concerning event-related potentials (ERP) compared to a group of normal controls and how three months of treatment with piracetam affects those changes. We found that the latencies of all waves are longer in the groups of subjects suffering from AD and MID compared to the normal controls, except for the N100 wave, which showed shorter latency in the AD group. Amplitudes were lower in the groups of patients suffering from AD and MID. These changes were most prominent for the P300 wave. Treatment with piracetam reduced those changes in the precognitive part, though it seemed to have no effect on the cognitive part.
AuthorsM Dabic-Jeftic, I Mikula
JournalFunctional neurology (Funct Neurol) 1993 Sep-Oct Vol. 8 Issue 5 Pg. 335-45 ISSN: 0393-5264 [Print] Italy
PMID8144060 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Piracetam
Topics
  • Acoustic Stimulation
  • Aged
  • Alzheimer Disease (diagnosis, drug therapy)
  • Cognition (drug effects)
  • Dementia, Multi-Infarct (diagnosis, drug therapy)
  • Evoked Potentials, Auditory (drug effects)
  • Evoked Potentials, Visual (drug effects)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Photic Stimulation
  • Piracetam (pharmacology, therapeutic use)
  • Wechsler Scales

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: